INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹1,036 Cr | ₹978 Cr | ₹655 Cr | ₹315 Cr | ₹244 Cr |
What is the latest Total Debt ratio of INDOCO REMEDIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹1,036 Cr |
| Mar2025 | ₹978 Cr |
| Mar2024 | ₹655 Cr |
| Mar2023 | ₹315 Cr |
| Mar2022 | ₹244 Cr |
How is Total Debt of INDOCO REMEDIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,036 Cr | 5.91 | |
| Mar2025 | ₹978 Cr | 49.28 | |
| Mar2024 | ₹655 Cr | 108.31 | |
| Mar2023 | ₹315 Cr | 28.79 | |
| Mar2022 | ₹244 Cr | - | |
Compare Total Debt of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,036.6 Cr | -5.4% | -11.9% | -23.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -5.4% |
-11.9% |
-23.5% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses